[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Views 4,359
Citations 0
In This Issue of JAMA
January 17, 2017

Highlights

Author Affiliations
 

Copyright 2017 American Medical Association. All Rights Reserved.

JAMA. 2017;317(3):229-231. doi:10.1001/jama.2016.12954
Research

In a prospective cohort study of 613 adults with a history of physician-diagnosed asthma in the past 5 years, Aaron and colleagues assessed whether a diagnosis of current asthma could be ruled out and asthma medications stopped. Participants were assessed with peak flow and symptom monitoring, spirometry, and bronchial challenge tests, and daily asthma medications were gradually tapered. The authors report that current asthma was ruled out in 203 study participants (33.1%) who were not using daily asthma medications or had medications weaned. In an Editorial, Hollingsworth and O’Connor discuss diagnosis and remission of adult-onset asthma.

Editorial

CME

The prevalence of diabetes has increased substantially in China. Bragg and colleagues assessed the proportional excess mortality associated with diabetes in an analysis of data from 512 869 adult participants in a nationwide prospective study. The authors found that diabetes was associated with increased mortality from a range of cardiovascular and noncardiovascular diseases. Although diabetes was more common in urban areas, diabetes-related excess mortality was greater in rural areas. In an Editorial, Chan discusses the epidemic of diabetes and diabetes-associated mortality in China.

Editorial

CME

In a retrospective cohort study of 184 875 adults admitted to the intensive care unit with suspected infection, Raith and colleagues assessed the prognostic accuracy of the Sequential [Sepsis-related] Organ Failure Assessment (SOFA) score, the quick SOFA (qSOFA) score, and the systemic inflammatory response syndrome criteria for in-hospital mortality. The authors report that an increase in the SOFA score of 2 or more had greater prognostic accuracy for in-hospital mortality than the SIRS criteria or qSOFA score. In an Editorial, Lamontagne and colleagues discuss use of the qSOFA score for rapid identification of patients with suspected infection who have, or will likely develop, sepsis.

Editorial

In a multicenter cohort study that enrolled 879 consecutive patients who presented to the emergency department (ED) with suspected infection, Freund and colleagues assessed the validity of the Sepsis-3 criteria, particularly the qSOFA score, in this setting. The authors report that use of the qSOFA score was associated with greater prognostic accuracy for in-hospital mortality than the systemic inflammatory response syndrome criteria or severe sepsis.

Editorial

Clinical Review & Education

This article by Minami and colleagues in the JAMA Performance Improvement series presents the following scenario: a woman with a history of a latex allergy presented for colectomy and ureteral stent placement. After a sign-in and time-out, the urology team placed bilateral ureteral stents and inserted a Foley catheter. Prior to progressing to the next portion of the case, the urology and nursing teams identified that a latex Foley catheter had been inserted. What would you do next?

Author Audio Interview and CME

Invasive fungal infections are important causes of morbidity and mortality among critically ill patients. This JAMA Clinical Evidence Synopsis by Cortegiani and colleagues summarizes a Cochrane review (22 randomized trials; 2761 total patients) that assessed the association of antifungal treatments administered prior to diagnosis of an invasive fungal infection with subsequent rates of invasive fungal infection and mortality among nonneutropenic critically ill patients in the intensive care unit (ICU).

The high price of epinephrine auto-injectors EpiPen and EpiPen Jr may prompt patient queries about alternative products to treat anaphylaxis. This article from The Medical Letter on Drugs and Therapeutics provides summary information about Adrenaclick and its generic equivalent—the only alternatives to EpiPen products currently available in the United States. Adrenaclick and its generic equivalent are not considered interchangeable with the EpiPen products due to differences in design and instructions for use.

×